DocGo Inc. Increase (Decrease) in Accounts Receivable
DocGo Inc. (DCGO) reported Increase (Decrease) in Accounts Receivable of -$3.84 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-17.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsReceivable · last filed 2026-08-17
- DocGo Inc. increase (decrease) in accounts receivable for the quarter ending 2026-06-30 was -$6.64M.
- DocGo Inc. increase (decrease) in accounts receivable for the quarter ending 2026-03-31 was $2.80M.
- DocGo Inc. increase (decrease) in accounts receivable for the quarter ending 2025-12-31 was -$11.78M.
- DocGo Inc. increase (decrease) in accounts receivable for the quarter ending 2025-09-30 was -$14.53M.
- DocGo Inc. increase (decrease) in accounts receivable for fiscal 2025 was -$112.50M.
- DocGo Inc. increase (decrease) in accounts receivable for fiscal 2024 was -$41.27M, a 125.71% decline from fiscal 2023.
- DocGo Inc. increase (decrease) in accounts receivable for fiscal 2023 was $160.52M, a 1807.42% increase from fiscal 2022.
- DocGo Inc. increase (decrease) in accounts receivable for fiscal 2022 was $8.42M, a 85.49% decline from fiscal 2021.
| Period end | Increase (Decrease) in Accounts Receivable 3 month | Increase (Decrease) in Accounts Receivable 6 month | Increase (Decrease) in Accounts Receivable 9 month | Increase (Decrease) in Accounts Receivable 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$6.64M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-17 | -$3.84M 10-Q · filed 2026-08-17 | -$15.61M derived: sum of 3 quarters · filed 2026-08-17 | -$30.14M derived: sum of 4 quarters · filed 2026-08-17 |
| 2026-03-31 | $2.80M 10-Q · filed 2026-05-11 | -$8.97M derived: sum of 2 quarters · filed 2026-05-11 | -$23.50M derived: sum of 3 quarters · filed 2026-05-11 | -$78.26M derived: sum of 4 quarters · filed 2026-08-17 |
| 2025-12-31 | -$11.78M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-16 | -$26.30M derived: sum of 2 quarters · filed 2026-03-16 | -$81.06M derived: sum of 3 quarters · filed 2026-08-17 | -$112.50M 10-K · filed 2026-03-16 |
| 2025-09-30 | -$14.53M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10 | -$69.28M derived: sum of 2 quarters · filed 2026-08-17 | -$100.72M 10-Q · filed 2025-11-10 | -$122.16M derived: sum of 4 quarters · filed 2026-08-17 |
| 2025-06-30 | -$54.76M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-17 | -$86.19M 10-Q · filed 2026-08-17 | -$107.63M derived: sum of 3 quarters · filed 2026-08-17 | -$129.02M derived: sum of 4 quarters · filed 2026-08-17 |
| 2025-03-31 | -$31.44M 10-Q · filed 2026-05-11 | -$52.87M derived: sum of 2 quarters · filed 2026-05-11 | -$74.26M derived: sum of 3 quarters · filed 2026-05-11 | -$95.11M derived: sum of 4 quarters · filed 2026-05-11 |
| 2024-12-31 | -$21.43M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-16 | -$42.82M derived: sum of 2 quarters · filed 2026-03-16 | -$63.67M derived: sum of 3 quarters · filed 2026-03-16 | -$41.27M 10-K · filed 2026-03-16 |
| 2024-09-30 | -$21.39M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10 | -$42.24M derived: sum of 2 quarters · filed 2025-11-10 | -$19.84M 10-Q · filed 2025-11-10 | $37.20M derived: sum of 4 quarters · filed 2026-03-16 |
| 2024-06-30 | -$20.85M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | $1.55M 10-Q · filed 2025-08-07 | $58.59M derived: sum of 3 quarters · filed 2026-03-16 | $146.67M derived: sum of 4 quarters · filed 2026-03-16 |
| 2024-03-31 | $22.40M 10-Q · filed 2025-05-08 | $79.44M derived: sum of 2 quarters · filed 2026-03-16 | $167.52M derived: sum of 3 quarters · filed 2026-03-16 | $158.26M derived: sum of 4 quarters · filed 2026-03-16 |
| 2023-12-31 | $57.04M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-16 | $145.12M derived: sum of 2 quarters · filed 2026-03-16 | $135.86M derived: sum of 3 quarters · filed 2026-03-16 | $160.52M 10-K · filed 2026-03-16 |
| 2023-09-30 | $88.08M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | $78.82M derived: sum of 2 quarters · filed 2024-11-07 | $103.48M 10-Q · filed 2024-11-07 | $114.79M derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-06-30 | -$9.26M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-07 | $15.41M 10-Q · filed 2024-08-07 | $26.72M derived: sum of 3 quarters · filed 2025-02-27 | $28.13M derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-03-31 | $24.67M 10-Q · filed 2024-05-08 | $35.98M derived: sum of 2 quarters · filed 2025-02-27 | $37.39M derived: sum of 3 quarters · filed 2025-02-27 | $34.15M derived: sum of 4 quarters · filed 2025-02-27 |
| 2022-12-31 | $11.31M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | $12.73M derived: sum of 2 quarters · filed 2025-02-27 | $9.48M derived: sum of 3 quarters · filed 2025-02-27 | $8.42M 10-K · filed 2025-02-27 |
| 2022-09-30 | $1.42M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-06 | -$1.83M derived: sum of 2 quarters · filed 2023-11-06 | -$2.89M 10-Q · filed 2023-11-06 | $26.31M derived: sum of 4 quarters · filed 2024-02-28 |
| 2022-06-30 | -$3.25M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-08 | -$4.31M 10-Q · filed 2023-08-08 | $24.89M derived: sum of 3 quarters · filed 2024-02-28 | $36.24M derived: sum of 4 quarters · filed 2024-02-28 |
| 2022-03-31 | -$1.06M 10-Q · filed 2023-05-09 | $28.14M derived: sum of 2 quarters · filed 2024-02-28 | $39.49M derived: sum of 3 quarters · filed 2024-02-28 | $49.80M derived: sum of 4 quarters · filed 2024-02-28 |
| 2021-12-31 | $29.20M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | $40.55M derived: sum of 2 quarters · filed 2024-02-28 | $50.86M derived: sum of 3 quarters · filed 2024-02-28 | $58.00M 10-K · filed 2024-02-28 |
| 2021-09-30 | $11.35M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08 | $21.66M derived: sum of 2 quarters · filed 2022-11-08 | $28.79M 10-Q · filed 2022-11-08 | |
| 2021-06-30 | $10.30M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09 | $17.44M 10-Q · filed 2022-08-09 | ||
| 2021-03-31 | $7.14M 10-Q · filed 2022-05-10 | |||
| 2020-12-31 | $16.15M 10-K · filed 2022-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| VSEE HEALTH, INC. (VSEE) | United States | $0.003B | |
| Agape ATP Corp (ATPC) | $0.002B | ||
| Strata Critical Medical, Inc. (SRTA) | United States | $0.467B | 11.33 |
| InnovAge Holding Corp. (INNV) | United States | $1.206B | -635.60 |
| Omada Health, Inc. (OMDA) | United States | $1.207B | 309.08 |
| U S PHYSICAL THERAPY INC /NV (USPH) | United States | $1.251B | 32.48 |
| Pennant Group, Inc. (PNTG) | United States | $1.386B | 39.84 |
| Privia Health Group, Inc. (PRVA) | United States | $2.477B | 115.52 |
| GeneDx Holdings Corp. (WGS) | United States | $2.638B | -19.23 |
| LifeStance Health Group, Inc. (LFST) | United States | $4.510B | 80.86 |